Research
Hormonal
Using semaglutide is associated with successful weight reduction at the follow-up of 6 months (OR = 2.138).
Semaglutide may be a more effective option for weight reduction in patients treated with GLP-1RA.
StrongSupportsmedium confidence
Non-diabetic status (OR = 2.176, 95% CI, 1.242-3.812) and using semaglutide (OR = 2.138, 95% CI, 1.162-3.935) were associated with successful weight reduction at the follow-up of 6 months.
Why this rating
Based on a retrospective cohort study with a substantial sample size.
Source
Glucagon‐like peptide‐1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity
Jingxuan Wang et al. · Diabetes Obesity and Metabolism · 2025
cohort · n=679Cited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →